NCT00461591 2021-03-30
Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611)
Spectrum Pharmaceuticals, Inc
Phase 3 Completed
Spectrum Pharmaceuticals, Inc
Spectrum Pharmaceuticals, Inc